Mesh : Anticoagulants / therapeutic use Antiphospholipid Syndrome / blood complications diagnosis drug therapy immunology Biomarkers / blood Fibrinolytic Agents / therapeutic use Humans Immunologic Tests / standards Lupus Coagulation Inhibitor / blood Odds Ratio Patient Selection Practice Guidelines as Topic Predictive Value of Tests Prognosis Risk Factors Thromboembolism / blood etiology immunology prevention & control
来 源: DOI:10.1016/j.thromres.2012.08.283